Drugs / buprenorphine/naloxone
last change Feb 2016 re-read 3 minutes ago

buprenorphine/naloxone

Developed for
opiate dependence
Investigated by
University of Wisconsin, Madison

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01843751 Mar 2013 → Feb 2016 opiate dependence University of Wisconsin, Madison Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as buprenorphine/naloxone ClinicalTrials.gov intervention name — accepted as the source's own label NCT01843751 ↗